These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34471161)

  • 21. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
    Sun X; Su VL; Calderwood DA
    J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting PAK1.
    Semenova G; Chernoff J
    Biochem Soc Trans; 2017 Feb; 45(1):79-88. PubMed ID: 28202661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
    Yellapu NK; Pulaganti M; Pakala SB
    J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insights into the autoactivation mechanism of p21-activated protein kinase.
    Wang J; Wu JW; Wang ZX
    Structure; 2011 Dec; 19(12):1752-61. PubMed ID: 22153498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational design of a PAK1 binding protein.
    Jha RK; Leaver-Fay A; Yin S; Wu Y; Butterfoss GL; Szyperski T; Dokholyan NV; Kuhlman B
    J Mol Biol; 2010 Jul; 400(2):257-70. PubMed ID: 20460129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.
    Han D; Wang H; Cui W; Zhang B; Chen BZ
    Future Med Chem; 2020 Mar; 12(5):367-385. PubMed ID: 32064922
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window.
    Rudolph J; Murray LJ; Ndubaku CO; O'Brien T; Blackwood E; Wang W; Aliagas I; Gazzard L; Crawford JJ; Drobnick J; Lee W; Zhao X; Hoeflich KP; Favor DA; Dong P; Zhang H; Heise CE; Oh A; Ong CC; La H; Chakravarty P; Chan C; Jakubiak D; Epler J; Ramaswamy S; Vega R; Cain G; Diaz D; Zhong Y
    J Med Chem; 2016 Jun; 59(11):5520-41. PubMed ID: 27167326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P21-activated kinase in inflammatory and cardiovascular disease.
    Taglieri DM; Ushio-Fukai M; Monasky MM
    Cell Signal; 2014 Sep; 26(9):2060-9. PubMed ID: 24794532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic Desulfated Saponin from
    Shahinozzaman M; Ishii T; Takano R; Halim MA; Hossain MA; Tawata S
    Sci Pharm; 2018 Aug; 86(3):. PubMed ID: 30200330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small peptide inhibitor from the sequence of RUNX3 disrupts PAK1-RUNX3 interaction and abrogates its phosphorylation-dependent oncogenic function.
    Kanumuri R; Chelluboyina AK; Biswal J; Vignesh R; Pandian J; Venu A; Vaishnavi B; Leena DJ; Jeyaraman J; Ganesan K; Aradhyam GK; Venkatraman G; Rayala SK
    Oncogene; 2021 Aug; 40(34):5327-5341. PubMed ID: 34253860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids.
    Bokoch GM; Reilly AM; Daniels RH; King CC; Olivera A; Spiegel S; Knaus UG
    J Biol Chem; 1998 Apr; 273(14):8137-44. PubMed ID: 9525917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
    Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
    Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of allosteric inhibitors of p21-activated kinase.
    Viaud J; Peterson JR
    Methods Mol Biol; 2012; 928():67-79. PubMed ID: 22956134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
    Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
    Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.
    Amirthalingam M; Palanisamy S; Tawata S
    Ageing Res Rev; 2021 Nov; 71():101443. PubMed ID: 34390849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphoinositides are essential coactivators for p21-activated kinase 1.
    Strochlic TI; Viaud J; Rennefahrt UE; Anastassiadis T; Peterson JR
    Mol Cell; 2010 Nov; 40(3):493-500. PubMed ID: 21070974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p21-activated kinase inhibitors.
    Rudolph J; Crawford JJ; Hoeflich KP; Chernoff J
    Enzymes; 2013; 34 Pt. B():157-80. PubMed ID: 25034104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated insulin secretion through activation of p21-activated kinase (PAK1) in pancreatic β-Cells.
    Nie J; Sun C; Faruque O; Ye G; Li J; Liang Q; Chang Z; Yang W; Han X; Shi Y
    J Biol Chem; 2012 Jul; 287(31):26435-44. PubMed ID: 22669945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why an A-loop phospho-mimetic fails to activate PAK1: understanding an inaccessible kinase state by molecular dynamics simulations.
    Ng YW; Raghunathan D; Chan PM; Baskaran Y; Smith DJ; Lee CH; Verma C; Manser E
    Structure; 2010 Jul; 18(7):879-90. PubMed ID: 20637424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.